Anti-Infective Medicines in Tanzania: NEMLIT medicines, brands and prices
Tanzania's National Essential Medicines List (NEMLIT, 7th edition, 2026) lists 121 medicines under Anti-Infective Medicines. None of them is on the DukaDawa pharmacy network yet.
Last updated
Sub-categories
- Access Group Antibiotics (19)
- Ant amoebic and Ant giardiasis Medicines (4)
- Ant filariasis (2)
- Anti-Herpes Medicines (2)
- Anti-malarial Medicines (6)
- Anti-schistosomiasis and Other Anti-trematode Medicines (1)
- Antifungal Medicines (13)
- Antipneumocystosis and ant toxoplasmosis medicines (3)
- Fixed Dose Combinations (6)
- Integrase Inhibitors and capsid inhibitor (3)
- Intestinal anthelminthics (2)
- Malaria Prophylaxis (3)
- Medicines for Hepatitis-B (3)
- Medicines for Hepatitis-C (2)
- Medicines for Prevention of Opportunistic Infections (1)
- Non-nucleoside Transcriptase Inhibitors (2)
- Nucleoside/Nucleotide Reverse Transcriptase Inhibitors (7)
- Protease Inhibitors (5)
- Reserve Group Antibiotics (23)
- Watch Group Antibiotics (14)
Which anti-infective medicines can I get on the DukaDawa pharmacy network?
None of the anti-infective medicines is on the DukaDawa pharmacy network yet.
Which anti-infective medicines are on Tanzania's NEMLIT?
The NEMLIT (7th edition, 2026) lists 121 medicines under Anti-Infective Medicines: Abacavir (ABC), Abacavir/Lamivudine, Abacavir/Lamivudine/Dolutegravir, Acyclovir, Albendazole, Amikacin, Amoxicillin and Amoxicillin + Clavulanic acid and 110 more.
| Medicine | Level | Category | Listed forms | Page |
|---|---|---|---|---|
| Abacavir (ABC) | A | Nucleoside/Nucleotide Reverse Transcriptase Inhibitors | Tablet: 300mg (as sulfate) | p. 10 |
| Abacavir/Lamivudine | A | Fixed Dose Combinations | Dispersible Tablet 60/30mg; Dispersible tablet; 120/60mg; Tablet 600/300mg Scored | p. 11 |
| Abacavir/Lamivudine/Dolutegravir | A | Fixed Dose Combinations | Dispersible Tablet 60/30/5 mg | p. 11 |
| Acyclovir | B, D | Anti-Herpes Medicines | Cream 5%; Tablet 200mg, 400mg, Injection 500mg/Vial | p. 10 |
| Albendazole | A | Intestinal anthelminthics | Suspension 100mg/5mL in 30mL bottle; Tablet 200mg, 400mg, chewable | p. 7 |
| Amikacin | S | Reserve Group Antibiotics | Injection 250mg/mL (as sulfate) | p. 8 |
| Amoxicillin | A, B | Access Group Antibiotics | Capsule (as trihydrate) 250mg; Dispersible tablet 250mg, 125mg Powder for suspension (as trihydrate) 125mg+ 31.25mg (as potassium salt) in 5mL AND 250mg amoxicillin + 62.5mg clavulanic acid/5mL; Tablet (as trihydrate) 500mg + 125mg | p. 7 |
| Amoxicillin + Clavulanic acid | C | Access Group Antibiotics | clavulanic acid (as potassium salt) Powder for injection 500mg (as sodium), + 100mg (as potassium salt) in vial | p. 7 |
| Amphotericin B Deoxycholate | S | Antifungal Medicines | Powder for injection 5mg/ml | p. 9 |
| Ampicillin | A | Access Group Antibiotics | Powder for injection (as sodium salt) 250mg, 500mg in vial | p. 7 |
| Ampicillin + cloxacillin | B | Access Group Antibiotics | Capsule 250/250mg, injection 250mg ,500mg | p. 7 |
| Ampicillin + Sulbactam | C | Access Group Antibiotics | Powder for injection (ampicillin 1g/sulbactam 0.5g), (ampicillin 2g/sulbactam 1g), (ampicillin 10g/sulbactam 5g) | p. 7 |
| Artemether | A | Anti-malarial Medicines | Injection 80mg/mL ampoules | p. 11 |
| Artemether/Lumefantrine (ALU) | A | Anti-malarial Medicines | Tablet 20mg/120mg | p. 11 |
| Artesunate | A | Anti-malarial Medicines | Injection: 30mg, 60mg,120mg | p. 11 |
| Artesunate + Amodiaquine | B | Anti-malarial Medicines | Tablet 25mg+ 67.5, 50mg+ 135mg, 100mg + 270mg | p. 11 |
| Atazanavir | A | Protease Inhibitors | Tablet 100mg; 300mg (as sulfate) | p. 10 |
| Atazanavir + Ritonavir (ATV/r) | A | Protease Inhibitors | Tablet: 300mg (as sulfate) + 100mg | p. 10 |
| Atovaquone + Proguanil | C | Malaria Prophylaxis | 62.5mg + 25mg, 250mg +100mg | p. 12 |
| Azithromycin | B | Watch Group Antibiotics | Capsule/Tablet (as dihydrate) 250 mg, 500 mg; Oral liquid 200 mg/5 mL (Level A for STI only) | p. 8 |
| Bedaquiline | S | Reserve Group Antibiotics | Tablet 100 mg | p. 9 |
| Benzathine benzylpenicillin | A | Access Group Antibiotics | Powder for injection 1.44g (2,400,000 IU) in vial | p. 7 |
| Benzoic acid Compound (Whitfield’s) | A | Antifungal Medicines | 3% salicylic acid and 6% benzoic acid ointment | p. 9 |
| Benzylpenicillin | A | Access Group Antibiotics | Powder for injection (as sodium or potassium salt) 3g (5,000,000 IU) in vial | p. 7 |
| Cefalexin | B | Access Group Antibiotics | Capsule 250mg (as monohydrate); Powder for reconstitution 125/5mi; 250mg/mL | p. 7 |
| Cefazolin | B | Access Group Antibiotics | Injection 500 mg/mL (For surgical prophylaxis) / C (for all other indications) | p. 7 |
| Cefepime | D | Watch Group Antibiotics | Injection 1000mg | p. 8 |
| Cefixime | S | Watch Group Antibiotics | Capsule 200 mg, 400 mg (Level A for STI and Typhoid only) | p. 8 |
| Cefotaxime | C | Watch Group Antibiotics | Powder for injection 500 mg, 1 g, 2 g vial; | p. 8 |
| Ceftazidime | D | Watch Group Antibiotics | Powder for injection (as pentahydrate) 250 mg vial | p. 8 |
| Ceftriaxone | B | Watch Group Antibiotics | Injection 250 mg, 500 mg, 1 g vial (Level A for STI only) | p. 8 |
| Ceftriaxone + Sulbactam | A, D | Watch Group Antibiotics | Injection 1.5 g vial Tablet (as hydrochloride) 250 mg, 500 mg | p. 8 |
| Cefuroxime | D | Watch Group Antibiotics | Powder for injection 250 mg, 750 mg, 1.5 g vial; Oral suspension 125 mg/5 mL, 250 mg/5 mL; Tablet 250 mg, 500 mg | p. 8 |
| Chloramphenicol | B | Access Group Antibiotics | Oily injection (as sodium succinate) 0.5 g/mL in 2 mL ampoule; Powder for injection 1 g; Oral suspension 125 mg/5 mL; Injection (as phosphate) 150 mg/mL in 2 mL ampoule | p. 7 |
| Ciprofloxacin | C | Watch Group Antibiotics | Solution for IV infusion 2 mg/mL in 100 mL | p. 8 |
| Clarithromycin | C | Watch Group Antibiotics | Tablet 250 mg, 500 mg | p. 8 |
| Clindamycin | S | Reserve Group Antibiotics | Capsule 150 mg (as hydrochloride); Injection (as phosphate) 150 mg/mL in 2 mL ampoule | p. 8 |
| Clofazimine | A | Reserve Group Antibiotics | Capsule 50 mg, 100 mg | p. 9 |
| Clotrimazole | A | Antifungal Medicines | Clotrimazole Vaginal cream (nitrate) 1%, 10%; Clotrimazole Pessaries 100mg; 500mg; Topical cream/Ointment Oral drops: 10 mg/mL | p. 9 |
| Cloxacillin | B | Access Group Antibiotics | Powder for injection (as sodium salt) 250mg; 500mg in vial | p. 8 |
| Colistin | S | Reserve Group Antibiotics | Powder for injection: 1 million IU (as colistemethate sodium) (equivalent to 34 mg colistin base activity) in vial. Powder for nebulizer solution: 1–2MIU via nebulizer | p. 9 |
| Cycloserine | S | Reserve Group Antibiotics | Tablet 250 mg | p. 9 |
| Dapsone | S | Reserve Group Antibiotics | Tablet 50mg, 100 mg (Level A for ant leprosy) | p. 9 |
| Darunavir | A | Protease Inhibitors | Tablet 75mg, 400mg, 600mg, 800mg | p. 10 |
| Delamanid | S | Reserve Group Antibiotics | Tablet 50 mg | p. 9 |
| Diethylcarbamazine | A | Ant filariasis | Tablet 50mg; 100mg | p. 7 |
| Dihydroartemisinin + Piperaquine | C | Anti-malarial Medicines | Tablet 20mg+160mg, 40mg+320mg, | p. 11 |
| Diloxanide | C | Ant amoebic and Ant giardiasis Medicines | Tablet: 500mg (as furoate) | p. 11 |
| Dolutegravir | A | Integrase Inhibitors and capsid inhibitor | Tablet:10mg; 50mg | p. 11 |
| Doxycycline | A | Access Group Antibiotics | Capsule (as hydrochloride), 100mg | p. 8 |
| Efavirenz (EFV) | A | Non-nucleoside Transcriptase Inhibitors | Tablet: 200mg; 600mg | p. 10 |
| Emtricitabine | A | Nucleoside/Nucleotide Reverse Transcriptase Inhibitors | Tablet 200mg | p. 10 |
| Entecavir | S | Medicines for Hepatitis-B | Tablet: 0.5mg | p. 11 |
| Erythromycin | A | Watch Group Antibiotics | Powder for suspension (as ethyl succinate), 125mg/5mL in 100mL bottle; Tablet (as stearate or ethyl succinate), 250mg, film Coated | p. 8 |
| Ethambutol | A | Reserve Group Antibiotics | Tablet (as hydrochloride) 150 mg, 400 mg | p. 9 |
| Flucloxacillin | C | Access Group Antibiotics | Injection (sodium): 250 mg Oral solution: 125mg/5mL Capsule: 250 mg | p. 8 |
| Flucloxacillin + Amoxicillin | C | Access Group Antibiotics | Tablet 500mg (as fixed dose combination) ; | p. 8 |
| Fluconazole | A, C | Antifungal Medicines | IV infusion 2mg/mL in vial Tablet/Capsule 150mg, 200mg | p. 9 |
| Flucytosine | S | Antifungal Medicines | Isotonic infusion solution containing flucytosine (1%) and 0.805% sodium chloride Tablet 250mg, 500mg | p. 10 |
| Folinic acid | S | Antipneumocystosis and ant toxoplasmosis medicines | Tablets: 5 mg, 10 mg, 15 mg, and 25 mg Injection: 10 mg/mL, 20 mg/ml. | p. 12 |
| Gentamicin | A | Watch Group Antibiotics | Injection (as sulfate) 40 mg/mL in 2 mL ampoule; 20 mg/mL in 2 mL ampoule | p. 8 |
| Griseofulvin | A | Antifungal Medicines | Tablet: 500mg | p. 10 |
| Imipenem + Cilastatin | S | Reserve Group Antibiotics | Powder for injection 500 mg + 500 mg vial | p. 9 |
| Isoniazid | A | Reserve Group Antibiotics | Tablet: 100 mg, 300 mg | p. 9 |
| Isoniazid | A | Medicines for Prevention of Opportunistic Infections | Tablet 300mg | p. 11 |
| Isoniazid + Rifapentine | A | Reserve Group Antibiotics | Tablet 300 mg + 300 mg | p. 9 |
| Itraconazole | D | Antifungal Medicines | Capsule/tablet: 100 mg, 200 mg Oral liquid: 10 mg/mL Cream: 1% | p. 10 |
| Ivermectin | A | Ant filariasis | Tablet 3mg, 6mg | p. 7 |
| Ketoconazole | C | Antifungal Medicines | Shampoo: 1%, 2% Cream: 2% | p. 10 |
| Lamivudine (3TC) | A | Nucleoside/Nucleotide Reverse Transcriptase Inhibitors | Oral Liquid 50mg/mL; Tablet: 150mg | p. 10 |
| Lenacapavir | C | Integrase Inhibitors and capsid inhibitor | Injection: 463.5mg/1.5 mL, Tablet 300mg | p. 11 |
| Levofloxacin | S | Reserve Group Antibiotics | Tablet 250 mg | p. 9 |
| Linezolid | S | Reserve Group Antibiotics | Injection for intravenous administration: 2mg/mL in 300mL bag; Tablet 400mg; 600mg | p. 9 |
| Liposomal Amphotericin B | S | Antifungal Medicines | Injection 5mg/ml | p. 9 |
| Lopinavir + Ritonavir (LPV/r) | A | Protease Inhibitors | Capsule 40mg + 10mg; Oral liquid 400mg + 100mg/5mL; Tablet 100mg + 25mg; 200mg + 50mg | p. 10 |
| Luliconazole | C | Antifungal Medicines | Cream: 1% | p. 10 |
| Mebendazole | A | Intestinal anthelminthics | Suspension 100mg/5mL in 30mL bottle; Tablet 100mg, chewable | p. 7 |
| Mefloquine | C | Malaria Prophylaxis | 250mg, 500mg, 750mg | p. 12 |
| Meropenem | S | Reserve Group Antibiotics | Injection 500 mg, 1000 mg | p. 9 |
| Metronidazole | A, B | Access Group Antibiotics | Suspension as (benzoate) 200mg/5mL in 100mL; Tablet 200mg Injection (I.V) 5mg/mL in 100mL bottle; | p. 8 |
| Metronidazole | A | Ant amoebic and Ant giardiasis Medicines | Suspension: 200mg/5mL; Tablet 200mg | p. 11 |
| Miconazole | A, C | Antifungal Medicines | Vaginal Pessaries, Topical cream/ointment Oral gel 2% | p. 10 |
| Moxifloxacin | S | Reserve Group Antibiotics | Tablet 400mg | p. 9 |
| Nevirapine (NVP) | A | Non-nucleoside Transcriptase Inhibitors | Oral liquid:50mg/5mL; Tablet 50mg (dispersible); 200mg | p. 10 |
| Nitazoxanide | D | Ant amoebic and Ant giardiasis Medicines | Tablet: 500 mg; Suspension: 100 mg/5 mL | p. 11 |
| Nitrofurantoin | A | Access Group Antibiotics | Tablet: 100mg | p. 8 |
| Nystatin | A | Antifungal Medicines | oral Suspension: 100,000 I.U/mL | p. 10 |
| Phenoxymethylpenicillin | A | Access Group Antibiotics | Powder for suspension 125mg/5mL; (as potassium salt), Tablet 250mg | p. 8 |
| Piperacillin + Tazobactam | S | Watch Group Antibiotics | Powder for injection 2 g + 250 mg vial; 4 g + 500 mg vial | p. 8 |
| Praziquantel | A | Anti-schistosomiasis and Other Anti-trematode Medicines | Tablet 600mg | p. 7 |
| Pretomanid | S | Reserve Group Antibiotics | Tablet 200 mg | p. 9 |
| Primaquine | A | Anti-malarial Medicines | Tablet (as phosphates) 2.5mg, 7.5mg, 15mg | p. 11 |
| Pyrazinamide | A | Reserve Group Antibiotics | Tablet 400 mg, 500 mg | p. 9 |
| Pyrimethamine | A | Antipneumocystosis and ant toxoplasmosis medicines | Tablet: 25 mg | p. 12 |
| Raltegravir | A | Integrase Inhibitors and capsid inhibitor | Tablet 25mg, 100mg, 400mg | p. 11 |
| Rifampicin | A | Reserve Group Antibiotics | Tablet 150 mg, 300 mg | p. 9 |
| Rifampicin + Isoniazid | A | Reserve Group Antibiotics | Capsule/Tablet 150 mg + 75 mg; 50 mg + 150 mg | p. 9 |
| Rifampicin + Isoniazid + Pyrazinamide | A | Reserve Group Antibiotics | Tablet 75 mg + 50 mg + 150 mg | p. 9 |
| Rifampicin + Isoniazid + Pyrazinamide + | A | Reserve Group Antibiotics | Tablet 150 mg + 75 mg + 400 mg + 275 mg | p. 9 |
| Ritonavir | A | Protease Inhibitors | Oral liquid 400mg/5mL; Tablet 25mg; 100mg | p. 10 |
| Sofosbuvir + Daclatasvir | C | Medicines for Hepatitis-C | Tablet 400mg + 60mg | p. 11 |
| Sofosbuvir + Velpatasvir | C | Medicines for Hepatitis-C | Tablet 400mg + 100mg | p. 11 |
| Streptomycin | A | Watch Group Antibiotics | Powder for injection 1 g vial | p. 8 |
| Sulfadiazine | A | Antipneumocystosis and ant toxoplasmosis medicines | Tablet: 500 mg | p. 12 |
| Sulfadoxine + Pyrimethamine | A | Malaria Prophylaxis | Tablet 500mg + 25mg | p. 12 |
| Sulfamethoxazole + Trimethoprim | A | Access Group Antibiotics | Suspension (Sulphamethoxazole 200 mg/5 mL + Trimethoprim 40 | p. 8 |
| Tenofovir /Emtricitabine | A | Fixed Dose Combinations | Tablet 300/200mg | p. 11 |
| Tenofovir alafenamide (TAF) / Lamivudine / | A | Nucleoside/Nucleotide Reverse Transcriptase Inhibitors | Tablet: 25mg + 300mg + 50mg | p. 10 |
| Tenofovir alafenamide fumarate (TAF) | D | Medicines for Hepatitis-B | Tablet: 10mg, 25mg | p. 11 |
| Tenofovir disoproxil fumarate (TDF) | A | Nucleoside/Nucleotide Reverse Transcriptase Inhibitors | Tablet: 300mg | p. 10 |
| Tenofovir disoproxil fumarate (TDF) | D | Medicines for Hepatitis-B | Tablet: 300mg | p. 11 |
| Tenofovir disoproxil fumarate / Lamivudine | A | Nucleoside/Nucleotide Reverse Transcriptase Inhibitors | / Tablet: 300mg + 300mg + 50mg | p. 10 |
| Tenofovir/Lamivudine/Dolutegravir | A | Fixed Dose Combinations | Dispersible tablet 60/30mg; Tablet 300/300/50mg | p. 11 |
| Tenofovir/Lamivudine/Efavirenz | A | Fixed Dose Combinations | Tablet 300/300/400mg | p. 11 |
| Terbinafine | C | Antifungal Medicines | Tablet 250mg; Topical cream | p. 10 |
| Tinidazole | B | Ant amoebic and Ant giardiasis Medicines | Tablet 500mg | p. 11 |
| Trimethoprim | D | Access Group Antibiotics | Tablet 100 mg, 200 mg | p. 8 |
| Valganciclovir | S | Anti-Herpes Medicines | Tablet 450mg | p. 10 |
| Vancomycin | S | Reserve Group Antibiotics | Capsule 125 mg, 250 mg (as hydrochloride); Powder for injection 250 mg vial | p. 9 |
| Zidovudine (AZT) | A | Nucleoside/Nucleotide Reverse Transcriptase Inhibitors | Capsule 250mg; Oral liquid 50mg/5mL | p. 10 |
| Zidovudine/Lamivudine | A | Fixed Dose Combinations | Tablet 300/150mg | p. 11 |
Who can prescribe anti-infective medicines in Tanzania?
It depends on each medicine's NEMLIT level. This category has medicines at levels A, B, C, D and S; level A medicines may be prescribed by specialists, medical officers, dental officers, assistant medical officers, clinical officers and assistant clinical officers.
| Level | Facility | Who may prescribe |
|---|---|---|
| A (listed) | Dispensary | Specialist, Medical Officer, Dental Officer, Assistant Medical Officer, Clinical Officer, Assistant Clinical Officer |
| B (listed) | Health centre | Specialist, Medical Officer, Dental Officer, Assistant Medical Officer, Clinical Officer |
| C (listed) | Council or district hospital | Specialist, Medical Officer, Dental Officer, Assistant Medical Officer |
| D (listed) | Regional referral hospital | Specialist, Medical Officer, Dental Officer |
| S (listed) | Zonal, special and national hospitals | Specialist |
New to DukadawaRx? Register as a prescriber. Licensed prescribers only; we verify your registration before you can prescribe.
Sources: Standard Treatment Guidelines and National Essential Medicines List (STG/NEMLIT), 7th edition, 2026, Ministry of Health; DukaDawa pharmacy network. Category names as printed in the NEMLIT.
This page supports licensed prescribers and pharmacists. It is not medical advice and does not replace the Standard Treatment Guidelines, the product information or professional judgement. Prices and stock change often: confirm with the pharmacy.